PAS
HCAT icon

Point72 Asia (Singapore)’s Health Catalyst HCAT Stock Holding History

Point72 Asia (Singapore)’s Portfolio HCAT Stock Details HCAT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,380
Closed -$15.2K – 1129
2024
Q2 		$15.2K Sell
2,380
-14,405
-86% -$92.5K ﹤0.01% 872
2024
Q1 		$126K Buy
+16,785
New +$153K 0.03% 574

Other funds holding HCAT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
DG
Daventry Group New York $133M AUM 32.28% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Point72 Asia (Singapore)'s HCAT Position: Q3 2024 in Review

Point72 Asia (Singapore) sold out of Health Catalyst (HCAT) in Q3 2024, closing a stake of 2,380 shares — an estimated $15.2K sold.

Point72 Asia (Singapore) first reported a position in HCAT in Q1 2024 and held it in 2 quarters. The position peaked at $126K in Q1 2024. 159 funds tracked by Wall St. Rank hold HCAT as of Q3 2024.

  • Point72 Asia (Singapore) reported no remaining Health Catalyst position as of Q3 2024 after selling out during the quarter.
  • Point72 Asia (Singapore) sold 2,380 Health Catalyst shares in Q3 2024, an estimated $15.2K.
  • Point72 Asia (Singapore) first reported a position in Health Catalyst in Q1 2024 and held it in 2 quarters.
  • Point72 Asia (Singapore)'s Health Catalyst position peaked at $126K in Q1 2024.
  • 159 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2024.

Based on Point72 Asia (Singapore)'s 13F filing for Q3 2024, filed 14 Nov 2024.